Tag: Orally administered therapeutic
Haoma Medica’s novel treatment for osteoporosis, NaQuinate, undergoes first human trial
Haoma Medica has announced the completion of a first-in-human trial for NaQuinate. A naphthoquinone carboxylic acid, it is being developed as a novel orally...
